| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| CCDC26 |
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
|
0.647 |
0.615 |
| MIR3936HG |
|
MIR3936 host gene
|
|
|
0.861 |
0.269 |
| CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
| CADM3-AS1 |
|
CADM3 antisense RNA 1
|
|
|
1.000 |
0.038 |
| LINC01478 |
|
long intergenic non-protein coding RNA 1478
|
|
|
1.000 |
0.077 |
| SEC1P |
|
secretory blood group 1, pseudogene
|
|
|
0.792 |
0.385 |
| MIR29B2CHG |
|
MIR29B2 and MIR29C host gene
|
|
|
0.839 |
0.192 |
| JAZF1-AS1 |
|
JAZF1 antisense RNA 1
|
|
|
1.000 |
0.115 |
| LINC02652 |
|
long intergenic non-protein coding RNA 2652
|
|
|
1.000 |
0.115 |
| KIF9-AS1 |
|
KIF9 antisense RNA 1
|
|
|
1.000 |
0.077 |
| THADA |
Q6YHU6
|
THADA armadillo repeat containing
|
Receptor
|
4.6E-41 |
0.686 |
0.500 |
| RASA2 |
Q15283
|
RAS p21 protein activator 2
|
Enzyme modulator
|
7.4E-31 |
0.579 |
0.769 |
| TRAP1 |
Q12931
|
TNF receptor associated protein 1
|
Chaperone
|
1.6E-29 |
0.590 |
0.615 |
| AHI1 |
Q8N157
|
Abelson helper integration site 1
|
|
1.1E-25 |
0.513 |
0.846 |
| PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
| MAST2 |
Q6P0Q8
|
microtubule associated serine/threonine kinase 2
|
Kinase
|
1.7E-19 |
0.760 |
0.192 |
| GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
| USP50 |
Q70EL3
|
ubiquitin specific peptidase 50
|
|
2.6E-18 |
|
|
| SLC12A7 |
Q9Y666
|
solute carrier family 12 member 7
|
Transporter
|
1.4E-17 |
0.769 |
0.385 |
| NOSTRIN |
Q8IVI9
|
nitric oxide synthase trafficking
|
|
3.2E-16 |
0.805 |
0.346 |
| RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
| MPO |
P05164
|
myeloperoxidase
|
Enzyme
|
7.1E-15 |
0.377 |
0.923 |
| C11orf65 |
Q8NCR3
|
chromosome 11 open reading frame 65
|
|
2.0E-14 |
0.670 |
0.462 |
| PRTFDC1 |
Q9NRG1
|
phosphoribosyl transferase domain containing 1
|
Enzyme
|
2.4E-13 |
0.805 |
0.385 |